Epacadostat and Pembrolizumab in Patients With GIST

NCT03291054 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Study ended prematurely at the request of the funding sponsor.

Conditions

Gastrointestinal Stromal Tumors

Interventions

DRUG: Pembrolizumab
DRUG: Epacadostat

Sponsor

Columbia University